You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

Published researchReproductive health researchFamily planning

11 Results Found

  • Published research

    Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican Republic

  • Published research

    “Men can take part”: Examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

  • Published research

    Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

  • Published research

    Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial

  • Published research

    Menstrual bleeding changes are NORMAL: Proposed counseling tool to address common reasons for non-use and discontinuation of contraception

    The authors reviewed commonly used family planning counseling, training and reference materials and found that menstrual bleeding changes were insufficiently addressed. The authors suggest using a new counseling mnemonic tool, “NORMAL,” that provides messages about changes associated with the use of hormonal contraception and the copper IUD.
  • Published research

    Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

    The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.
  • Published research

    Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: A systematic review

    Progestin-only contraceptive implants and injectables protect against ectopic pregnancy by being highly effective in preventing pregnancy overall. However, in the case of method failure, levonorgestrel (LNG)-containing contraceptive implants may be more likely to result in ectopic pregnancies than other methods, such as combined hormonal and barrier contraceptives. Women using LNG-containing implants, such as Jadelle or Sino-implant (II), and their providers should be aware of potential signs of ectopic pregnancy on the small chance the method should fail.
  • Published research

    Immediate postpartum insertion of intrauterine device for contraception (review)

    Of 15 trials in this systematic review, seven examined immediate versus later insertion of intrauterine contraception. Insertion immediately (within 10 minutes) after a placenta delivery reduces the risk of a subsequent pregnancy and eliminates the need for a return visit to start contraception. The benefit of effective contraception immediately after delivery may outweigh increased expulsion risk.
  • Published research

    Contraceptive efficacy, safety, fit and acceptability of a single-size diaphragm developed with end-user input

    A newly developed diaphragm is as effective as the standard diaphragm in preventing pregnancy. This non-latex, one-size-fits-most diaphragm, designed for comfort and easy use, has a good safety profile and was approved by the U.S. Food and Drug Administration in September 2014. Based on this study, the new device expands women's options for safe, effective, nonhormonal contraception.
  • Published research

    Towards the development of a longer-acting injectable contraceptive: Past research and current trends

    A longer-acting injectable contraceptive that lasts for six months would be a valuable addition to the contraceptive method mix and ideal for women who are interested in spacing births or uncertain about their future reproductive plans. This paper reviews past applications of drug delivery technologies to injectable contraceptives and recent advancements in sustained drug delivery technologies that hold promise for the development of a new longer-acting injectable contraceptive product. It also makes recommendations for the most promising approaches.